Presenilin-1 and -2 Are Molecular Targets for γ-Secretase Inhibitors*
暂无分享,去创建一个
Robert A. Copeland | David W. Robertson | Qian Wang | S. Arneric | R. Copeland | D. Seiffert | R. Olson | D. Rominger | A. Stern | D. Robertson | J. Meredith | P. Hartig | A. Combs | J. Higaki | L. Thompson | Dietmar Seiffert | David H. Rominger | Jodi Bradley | Lorin A. Thompson | Robert Zaczek | C. Rominger | Andrew M. Stern | Andrew P. Combs | Fude Yang | Barbara Cordell | Jere E. Meredith | Richard E. Olson | Stephen P. Arneric | Paul R. Hartig | Arthur H. Roach | Jeffrey N. Higaki | Shimoga R. Prakash | Jodi D. Bradley | Cynthia M. Rominger | Susan M. Spitz | R. Zaczek | S. Prakash | B. Cordell | A. Roach | Fude Yang | S. Spitz | Qian Wang | D. W. Robertson
[1] Alfredo G. Tomasselli,et al. Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity , 1999, Nature.
[2] P. Beckett,et al. A Short Diastereoselective Synthesis of 2,3-Disubstituted Succinates , 1993 .
[3] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[4] C. Czech,et al. Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms , 2000, Progress in Neurobiology.
[5] Sarah Tomlin,et al. Microtechnology: Laying it on thick , 1999, Nature.
[6] J. Tang,et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] D. Selkoe,et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity , 1999, Nature.
[8] B. Strooper,et al. The presenilins in Alzheimer's disease--proteolysis holds the key. , 1999, Science.
[9] B. Strooper,et al. Alzheimer's disease: A firm base for drug development , 1999, Nature.
[10] H. Vanderstichele,et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] Hugo Vanderstichele,et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein , 1998, Nature.
[12] R. Barbour,et al. Purification and cloning of amyloid precursor protein β-secretase from human brain , 1999, Nature.
[13] D. Selkoe,et al. The Proteolytic Fragments of the Alzheimer’s Disease-associated Presenilin-1 Form Heterodimers and Occur as a 100–150-kDa Molecular Mass Complex* , 1998, The Journal of Biological Chemistry.
[14] N. Hooper,et al. Membrane protein secretases. , 1997, The Biochemical journal.
[15] J. Treanor,et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.
[16] P. Fraser,et al. The Presenilin 1 Protein Is a Component of a High Molecular Weight Intracellular Complex That Contains β-Catenin* , 1998, The Journal of Biological Chemistry.
[17] P. Harden,et al. A combinatorial approach to the identification of dipeptide aldehyde inhibitors of beta-amyloid production. , 1999, Journal of medicinal chemistry.
[18] S. Lincoln,et al. A Loss of Function Mutation of Presenilin-2 Interferes with Amyloid β-Peptide Production and Notch Signaling* , 1999, The Journal of Biological Chemistry.
[19] C. Haass. Presenilins: Genes for Life and Death , 1997, Neuron.
[20] E. Harlow,et al. Using Antibodies: A Laboratory Manual , 1999 .
[21] M. Wolfe,et al. Inhibition of β-amyloid formation as a therapeutic strategy , 1999 .